Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Document › Details

Danaher Corporation. (6/30/11). "Press Release: Danaher Completes Acquisition of Beckman Coulter". Washington, DC.

Region Region United States (USA)
Organisations Organisation Danaher Corporation (NYSE: DHR)
  Group Danaher (Group)
  Organisation 2 Beckman Coulter Inc.
  Group Danaher (Group)
Products Product laboratory automation equipment
  Product 2 diagnostics (medical/biological)
Index term Index term Beckman Coulter–Danaher: investment, 201102–201106 acquisition cash tender offer $6.8b $83.5/share
Person Person McGrew, Matthew R. (Matt) (Danaher 20901–CFO joined 2012 before KPMG)

Danaher Corporation (NYSE:DHR) announced today the completion of its acquisition of Beckman Coulter, Inc. (NYSE: BEC) following the June 29, 2011 expiration, as of midnight, New York City time, of the subsequent offering period in the tender offer made by Danaher's indirect wholly owned subsidiary, Djanet Acquisition Corp., for all of the outstanding shares of Beckman Coulter, Inc. common stock. The initial tender offer period expired on June 24, 2011.

According to the final report of the depositary for the offer, as of the expiration of the subsequent offering period, a total of approximately 66,168,634 shares of Beckman Coulter common stock had been validly tendered and not withdrawn into the offer (including shares tendered during the subsequent offering period and excluding shares previously tendered pursuant to guaranteed delivery procedures that were not actually delivered), representing approximately 92.38% of outstanding shares of Beckman Coulter common stock. Stockholders who validly tendered and did not withdraw their shares will promptly receive the offer price of $83.50 per share, net to the seller in cash without interest.

On June 30, 2011, Danaher completed the merger of Djanet Acquisition Corp. into Beckman Coulter, Inc. and, as a result, Beckman Coulter has become an indirect wholly owned subsidiary of Danaher. In the merger, each outstanding share of Beckman Coulter common stock was cancelled and (except for shares held by Danaher, Djanet, Beckman Coulter and their respective subsidiaries and shares held by Beckman Coulter's stockholders who have and validly exercise appraisal rights under Delaware law) converted into the right to receive $83.50 per share, net to the seller in cash without interest.

Beckman Coulter's common stock will cease to be traded on the New York Stock Exchange. Detailed instructions will be mailed to former Beckman Coulter stockholders who did not tender their shares into the offer outlining the steps to be taken to obtain the merger consideration of $83.50 per share in cash, without interest.

About Danaher

Danaher Corporation is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Its portfolio of premier brands is among the most highly recognized in each of the markets it serves. Driven by a foundation provided by the Danaher Business System, Danaher's 48,000 associates serve customers in more than 125 countries and generated $12.8 billion of revenue in 2010. For more information please visit Danaher's website:


Matt R. McGrew
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860

Record changed: 2016-03-19


Picture [iito] No Tracking 650x80px

More documents for Danaher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Männer Ballett 650x80px

» top